NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -68.20K | -581.10K | -387.40K | -570.30K | -540.50K |
| Total Depreciation and Amortization | 1.61M | 1.64M | 1.66M | 1.67M | 1.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 707.50K | 797.10K | 769.90K | 808.20K | 849.50K |
| Change in Net Operating Assets | -585.30K | 921.30K | 645.00K | -58.40K | 828.30K |
| Cash from Operations | 1.75M | 2.86M | 2.68M | 1.85M | 2.80M |
| Capital Expenditure | -623.20K | -519.00K | -639.50K | -468.10K | -676.10K |
| Sale of Property, Plant, and Equipment | -- | -- | 11.40K | 11.40K | 11.40K |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -104.00K | -104.00K | -- | -- | -- |
| Cash from Investing | -727.20K | -623.00K | -628.00K | -456.60K | -664.60K |
| Total Debt Issued | 0.00 | 6.50M | 6.48M | 6.50M | 6.50M |
| Total Debt Repaid | -2.10M | -7.89M | -7.69M | -7.59M | -7.63M |
| Issuance of Common Stock | 259.00K | 259.00K | -- | -- | -- |
| Repurchase of Common Stock | -410.00K | -411.00K | -397.00K | -131.00K | -81.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -68.00K | -61.00K | 214.00K | 213.00K | 103.00K |
| Cash from Financing | -1.66M | -1.15M | -1.01M | -735.30K | -808.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -637.80K | 1.08M | 1.04M | 660.00K | 1.33M |